Literature DB >> 28256039

Biotransformation of ginsenoside Rb1 to ginsenoside Rg3 by endophytic bacterium Burkholderia sp. GE 17-7 isolated from Panax ginseng.

Y Fu1, Z-H Yin2, C-Y Yin2.   

Abstract

AIMS: To isolate a novel endophytic bacterium from Panax ginseng that could have excellent properties in converting ginsenoside Rb1 to ginsenoside Rg3. METHODS AND
RESULTS: Based on a 16S rDNA gene sequence, the strain named GE 17-7 was identified as Burkholderia sp. This strain has shown the highest activity in converting ginsenoside Rb1 to 20(S)-ginsenoside Rg3. During the biotransformation of ginsenoside Rb1, the final metabolite was identified by nuclear magnetic resonance analysis and the transformation pathway of ginsenoside Rb1 was also identified by thin-layer chromatography and high performance liquid chromatography analysis in this study.
CONCLUSIONS: We have successfully isolated a β-glucosidase-producing endophytic bacterium GE 17-7 from P. ginseng. Ginsenoside Rg3 was produced by strain GE 17-7 from ginsenoside Rb1 via ginsenoside Rd. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of the conversion of major ginsenoside Rb1 into minor ginsenoside Rg3 by fermentation with Burkholderia sp. endophytic bacteria in P. ginseng. These results suggest a new preparation method for ginsenoside Rg3 using strain GE 17-7 in the pharmaceutical industry.
© 2017 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Panax ginsengzzm321990; biotransformation; endophytic bacteria; ginsenoside Rb1; ginsenoside Rg3

Mesh:

Substances:

Year:  2017        PMID: 28256039     DOI: 10.1111/jam.13435

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  11 in total

Review 1.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

Review 2.  Prospecting potential of endophytes for modulation of biosynthesis of therapeutic bioactive secondary metabolites and plant growth promotion of medicinal and aromatic plants.

Authors:  Devendra Singh; Shobit Thapa; Himanshu Mahawar; Dharmendra Kumar; Neelam Geat; S K Singh
Journal:  Antonie Van Leeuwenhoek       Date:  2022-04-23       Impact factor: 2.271

3.  Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review.

Authors:  Qiang Tong; Peng-Chong Zhu; Zhuang Zhuang; Li-Hui Deng; Zi-Hao Wang; Hua Zeng; Guo-Qing Zheng; Yan Wang
Journal:  Front Pharmacol       Date:  2019-10-17       Impact factor: 5.810

Review 4.  Beneficial Relationships Between Endophytic Bacteria and Medicinal Plants.

Authors:  Wei Wu; Wenhua Chen; Shiyu Liu; Jianjun Wu; Yeting Zhu; Luping Qin; Bo Zhu
Journal:  Front Plant Sci       Date:  2021-04-22       Impact factor: 5.753

Review 5.  Bacterial endophytes from ginseng and their biotechnological application.

Authors:  Luan Luong Chu; Hanhong Bae
Journal:  J Ginseng Res       Date:  2021-04-17       Impact factor: 6.060

Review 6.  The Endosphere Microbiome of Ginseng.

Authors:  Paul H Goodwin
Journal:  Plants (Basel)       Date:  2022-02-02

Review 7.  A review for discovering bioactive minor saponins and biotransformative metabolites in Panax quinquefolius L.

Authors:  Zhiyou Yang; Jiahang Deng; Mingxin Liu; Chuantong He; Xinyue Feng; Shucheng Liu; Shuai Wei
Journal:  Front Pharmacol       Date:  2022-08-01       Impact factor: 5.988

Review 8.  Bacterial Endophytes: The Hidden Actor in Plant Immune Responses against Biotic Stress.

Authors:  Nadira Oukala; Kamel Aissat; Victoria Pastor
Journal:  Plants (Basel)       Date:  2021-05-19

Review 9.  Endophytes: the novel sources for plant terpenoid biosynthesis.

Authors:  Yachao Chen; Bing Hu; Jianmin Xing; Chun Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-28       Impact factor: 4.813

Review 10.  Study on Transformation of Ginsenosides in Different Methods.

Authors:  Meng-Meng Zheng; Fang-Xue Xu; Yu-Juan Li; Xiao-Zhi Xi; Xiao-Wei Cui; Chun-Chao Han; Xue-Lan Zhang
Journal:  Biomed Res Int       Date:  2017-12-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.